Aktiesnakken — Marts 2010
-
-
patentkrænkelse?
-
det er vist nok en gammel omgang, men interessant at det kommer nu
-
men genentech og biogen har lige fået patentet d. 23.mar står der
-
lidt ned
-
70, nu
-
70,5*
-
det er så stort et marked at alle kneb gælder
-
-
jo det vil jeg tro
-
men der var der lige nogen der panikkede
-
men hvordan man kan krænke et patent til behandling af patienter som netop IKKE har gavn af rituxian er nok lidt far fetched
-
er der nogen der kan støve det patent op?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind